Deficiency of GSDMD in mice typically leads to relief of the NASH phenotype, including reduction of inflammation, attenuation of steatosis, and amelioration of fibrosis, while overexpression of GSDMD augments liver inflammation and steatosis following feeding of an MCD diet (Xu et al., 2018). Here, GSDMD is linked to metabolic dysfunction-associated steatohepatitis.